4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-056440
Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
- Interim CEO & General Counsel acquired 52,085 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2025-06-02 | Option exercise | +52,085 | 426,731 | D: show line 1 in the form | ||
| Vogt Frederick G Interim CEO & General Counsel | 2025-06-02 | Shares withheld for taxes | −22,127 | $1.76 | $38,944 | 404,604 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2025-06-02 | Option exercise · Restricted Stock Units | −10,417 | 31,252 | D: show line 3 in the form | |||||
| Vogt Frederick G Interim CEO & General Counsel | 2025-06-02 | Option exercise · Restricted Stock Units | −41,668 | 291,682 | D: show line 4 in the form |
Loading xslF345X05/tm2517077-4_4seq1.xml…